Vascular remodelling in the pathogenesis of idiopathic pulmonary fibrosis

被引:58
作者
Barratt, S. [1 ]
Millar, A. [1 ]
机构
[1] Univ Bristol, Acad Resp Unit, Sch Clin Sci, Southmead Hosp, Southmead BS10 5NB, Avon, England
基金
英国惠康基金;
关键词
ENDOTHELIAL GROWTH-FACTOR; BRONCHOALVEOLAR LAVAGE; CXC CHEMOKINES; LUNG-DISEASES; ANGIOGENESIS; HYPERTENSION; BLEOMYCIN; ENDOSTATIN; APOPTOSIS; RATS;
D O I
10.1093/qjmed/hcu012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible fibrosing interstitial pneumonia of unknown aetiology that usually leads to respiratory failure and death within 5 years of diagnosis. Alveolar epithelial cell injury, disruption of alveolar capillary membrane integrity and abnormal vascular repair and remodelling have all been proposed as possible pathogenic mechanisms. This review summarizes our current knowledge of the abnormalities in vascular remodelling observed in IPF and highlights several of the cytokines thought to play a pathogenic role, which may ultimately prove to be future therapeutic targets.
引用
收藏
页码:515 / 519
页数:5
相关论文
共 28 条
[1]   Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis [J].
Collard, HR ;
King, TE ;
Bartelson, BB ;
Vourlekis, JS ;
Schwarz, MI ;
Brown, KK .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) :538-542
[2]   Pigment epithelium - derived factor in idiopathic pulmonary fibrosis - A role in aberrant angiogenesis [J].
Cosgrove, GP ;
Brown, KK ;
Schiemann, WP ;
Serls, AE ;
Parr, JE ;
Geraci, MW ;
Schwarz, MI ;
Cool, CD ;
Worthen, GS .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (03) :242-251
[3]   Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis [J].
Ebina, M ;
Shimizukawa, M ;
Shibata, N ;
Kimura, Y ;
Suzuki, T ;
Endo, M ;
Sasano, H ;
Kondo, T ;
Nukiwa, T .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (11) :1203-1208
[4]   The profibrotic cytokine transforming growth factor-ß1 increases endothelial progenitor cell angiogenic properties [J].
Evrard, S. M. ;
D'audigier, C. ;
Mauge, L. ;
Israel-Biet, D. ;
Guerin, C. L. ;
Bieche, I. ;
Kovacic, J. C. ;
Fischer, A. -M. ;
Gaussem, P. ;
Smadja, D. M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (04) :670-679
[5]   Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis A Tale of Angiogenesis, Apoptosis, and Growth Factors [J].
Farkas, Laszlo ;
Gauldie, Jack ;
Voelkel, Norbert F. ;
Kolb, Martin .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2011, 45 (01) :1-15
[6]   VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats [J].
Farkas, Laszlo ;
Farkas, Daniela ;
Ask, Kjetil ;
Moeller, Antje ;
Gauldie, Jack ;
Margetts, Peter ;
Inman, Mark ;
Kolb, Martin .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (05) :1298-1311
[7]   Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice [J].
Hamada, N ;
Kuwano, K ;
Yamada, M ;
Hagimoto, N ;
Hiasa, K ;
Egashira, K ;
Nakashima, N ;
Maeyama, T ;
Yoshimi, M ;
Nakanishi, Y .
JOURNAL OF IMMUNOLOGY, 2005, 175 (02) :1224-1231
[8]   Angiogenesis in Pulmonary Fibrosis Too Much or Not Enough? [J].
Hanumegowda, Chandru ;
Farkas, Laszlo ;
Kolb, Martin .
CHEST, 2012, 142 (01) :200-207
[9]  
Keane MP, 1997, J IMMUNOL, V159, P1437
[10]   Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis [J].
Koyama, S ;
Sato, E ;
Haniuda, M ;
Numanami, H ;
Nagai, S ;
Izumi, T .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (03) :382-385